Healthcare provider profile · identity verified

Daniel Malone, MD

Internal Medicine · LAS VEGAS, NV · NPI 1538132022

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	325	111
Amlodipine Besylate	Amlodipine Besylate	262	89
Levothyroxine Sodium	Levothyroxine Sodium	216	66
Lisinopril	Lisinopril	170	58
Simvastatin	Simvastatin	167	49
Losartan Potassium	Losartan Potassium	156	55
Omeprazole	Omeprazole	156	53
Metformin Hcl	Metformin Hcl	135	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	126	37
Rosuvastatin Calcium	Rosuvastatin Calcium	121	41
Alprazolam	Alprazolam	91	22
Zolpidem Tartrate	Zolpidem Tartrate	89	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	21
Hydrochlorothiazide	Hydrochlorothiazide	84	26
Metoprolol Succinate	Metoprolol Succinate	84	31
Pantoprazole Sodium	Pantoprazole Sodium	76	30
Metoprolol Tartrate	Metoprolol Tartrate	74	27
Eliquis	Apixaban	72	22
Testosterone Cypionate	Testosterone Cypionate	71	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	66	25
Gabapentin	Gabapentin	60	24
Tamsulosin Hcl	Tamsulosin Hcl	59	23
Glipizide Er	Glipizide	53	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Allopurinol	Allopurinol	41	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	38
Pravastatin Sodium	Pravastatin Sodium	39	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	14
Alendronate Sodium	Alendronate Sodium	38	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Diclofenac Sodium	Diclofenac Sodium	36	15
Nifedipine Er	Nifedipine	36	11
Montelukast Sodium	Montelukast Sodium	34	11
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Famotidine	Famotidine	33	13
Atenolol	Atenolol	32	11
Fenofibrate	Fenofibrate	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Potassium Chloride	Potassium Chloride	32	11
Diazepam	Diazepam	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	15
Furosemide	Furosemide	31	13
Carvedilol	Carvedilol	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	12
Ibuprofen	Ibuprofen	28	15
Trazodone Hcl	Trazodone Hcl	28	15
Metformin Hcl Er	Metformin Hcl	27	12
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Glipizide	Glipizide	24	suppressed
Felodipine Er	Felodipine	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Estradiol	Estradiol	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Acyclovir	Acyclovir	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Finasteride	Finasteride	15	suppressed
Azithromycin	Azithromycin	14	13
Lamotrigine	Lamotrigine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Folic Acid	Folic Acid	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error